They will get paid $1 million USD from the Mastercard agreement later in 2022 (1st half of FY 2023).
"The Agreement will see Mastercard provide Change with a cash incentive of US$1 million (A$1.4 million 1) upon launch of the first direct issuing program which is expected in H1 FY23, along with other incentives throughout the term. The increased collaboration with Mastercard will also provide opportunities to enhance Change’s PaaS offering through data, technology and relationships."
Will have to see how the cash flow goes in the next couple of quarters and any further customer announcements related to their Payments as a service Vertexon solution or any more customers signing up for Paysim API solution.
"First PaySim API sale – ANZ Bank in Australia became the first client to licence the new PaySim API. There is strong demand for the API from existing and new clients."
So with the loan and the Mastercard payment, maybe they have things covered until the ongoing repeatable revenue starts to pick up. If they can sign some larger Vertexon customers with future committed revenue, it would certainly help.
And even if they needed to do an additional capital raise the market would see that they aren't just burning through money, but actually have a plan to get to positive cash flow and potential profits.
- Forums
- ASX - By Stock
- General discussion CCA Earnings
They will get paid $1 million USD from the Mastercard agreement...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCA (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
-0.001(1.33%) |
Mkt cap ! $46.44M |
Open | High | Low | Value | Volume |
7.5¢ | 7.6¢ | 7.4¢ | $103.2K | 1.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150000 | 0.075 |
1 | 176862 | 0.074 |
1 | 25099 | 0.073 |
3 | 40251 | 0.072 |
2 | 314098 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 100000 | 1 |
0.080 | 47316 | 2 |
0.085 | 20000 | 1 |
0.096 | 150000 | 1 |
0.098 | 37500 | 1 |
Last trade - 15.55pm 15/07/2024 (20 minute delay) ? |
Featured News
CCA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online